Sinovac Biotech Ltd (SVA) 5.98 $SVA Global Rubella

New Post Public Reply Private Reply Replies (0) Message Board

Jun 23, 2016 at 3:10 AM

Sinovac Biotech Ltd (SVA) 5.98 $SVA

Global Rubella Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Sinovac Biotech, Biological E, Prometheon Pharma - Research and Markets
BusinessWire - Thu Jun 09, 9:01AM CDT
Research and Markets has announced the addition of the "Rubella - Pipeline Review, H1 2016" report to their offering.
SVA: 5.98 (+0.06)

Sinovac Reports Unaudited First Quarter 2016 Financial Results
PR Newswire - Thu May 26, 5:00PM CDT
Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter ended March 31, 2016.
SVA: 5.98 (+0.06)

Sinovac to Host Conference Call to Report First Quarter of 2016 Unaudited Financial Results
PR Newswire - Fri May 20, 5:03AM CDT
Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the first quarter, ended March 31, 2016, after the market closes on Thursday, May 26, 2016. The Company will host a conference call on Friday, May 27, 2016, at 8:00 a.m. EDT (Friday, May 27, 2016 at 8:00 p.m. China Standard Time) to review the Company's financial results and provide an update on recent corporate developments.
SVA: 5.98 (+0.06)

Simavita Announces Change to the Board
Marketwire Canada - Fri May 06, 9:59AM CDT
SYDNEY, AUSTRALIA--(Marketwired - May 6, 2016) - Simavita Limited ("Simavita" or the "Company"

(TSX VENTURE:SV)(ASX:SVA) today announced that, as foreshadowed in the changes to board and management announced on April 27, 2016, Craig Holland, Non-Executive Director and Chairman of the Audit & Risk Committee has resigned from the Board of Directors effective immediately.
SV.VN: 0.035 (-0.005), SVA: 5.98 (+0.06)

Simavita Announces Changes to the Board and Management; Strong Support from Existing Shareholders for the Company; Additional Financing / Issue of Notes
Marketwired - Wed Apr 27, 7:02AM CDT
Simavita Limited ("Simavita" or the "Company"

(TSX VENTURE: SV)(ASX: SVA) today announced that the Company, supported by its major shareholders, has completed a review of its Board, operations; executive management and working capital.
RMD: 62.33 (+0.55), SV.VN: 0.035 (-0.005), SVA: 5.98 (+0.06)

Sinovac Files 2015 Annual Report on Form 20-F
PR Newswire - Tue Apr 26, 3:12AM CDT
Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that it has filed its 2015 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2015 on April 25, 2016. The Annual Report on Form 20-F is now available on the Company's website under SEC Filings in the Investor Relations section.
SVA: 5.98 (+0.06)

Sinovac Special Committee Engages Financial and Legal Advisors
PR Newswire - Thu Apr 14, 5:00AM CDT
Sinovac Biotech Ltd. ("Sinovac" or the "Company"

(NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the independent special committee of the Company's Board of Directors, formed to consider "going private" proposals received by the Company, has appointed yesterday Duff & Phelps (Duff & Phelps, LLC and Duff & Phelps Securities, LLC) as its financial advisor to assist it in this process. The special committee has also appointed Weil, Gotshal & Manges as its U.S. legal counsel, and Leslie-Ann Brissett Legal Services as its Antigua counsel. Latham & Watkins is serving as U.S. legal counsel, and Delaney Law is serving as Antigua legal counsel, to the Company.
SVA: 5.98 (+0.06)

Sinovac posts 4Q profit
Automated Insights - Tue Apr 05, 5:37AM CDT
BEIJING (AP) _ Sinovac Biotech Ltd. (SVA) on Tuesday reported fourth-quarter net income of $504,000.
SVA: 5.98 (+0.06)

Sinovac Reports Unaudited Fourth Quarter and Full Year 2015 Financial Results
PR Newswire - Tue Apr 05, 5:16AM CDT
Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited fourth quarter and twelve month financial results for the period ended December 31, 2015.
SVA: 5.98 (+0.06)

Simavita to Integrate SIM(TM) With Leading North American Electronic Health Record Provider PointClickCare
Marketwire Canada - Mon Apr 04, 10:57AM CDT
Highlights
SV.VN: 0.035 (-0.005), SVA: 5.98 (+0.06)

Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2015 Unaudited Financial Results
PR Newswire - Tue Mar 29, 5:00AM CDT
Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the fourth quarter and full year, ended December 31, 2015, before market opens on Tuesday, April 5, 2016. The Company will host a conference call on Tuesday, April 5, 2016, at 8:00 a.m. EDT (Tuesday, April 5, 2015 at 8:00 p.m. China Standard Time) to review the Company's financial results and provide an update on recent corporate developments.
SVA: 5.98 (+0.06)

Sinovac Adopts Shareholder Rights Plan and Declares Dividend Distribution of Preferred Share Purchase Rights
PR Newswire - Mon Mar 28, 5:00PM CDT
Sinovac Biotech Ltd. ("Sinovac" or the "Company"

(NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that its board of directors has adopted a shareholder rights plan (the "Rights Plan"

, pursuant to which the board of directors declared a dividend distribution of one preferred share purchase right on each outstanding common share of the Company.
SVA: 5.98 (+0.06)

Shares of SVA Up 12.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Mar 07, 4:20PM CST
SmarTrend identified an Uptrend for Sinovac Biotech (AMEX:SVA) on February 1st, 2016 at $5.69. In approximately 1 month, Sinovac Biotech has returned 12.51% as of today's recent price of $6.40.
SVA: 5.98 (+0.06)

Simavita Limited: Issue of Placement Securities
Marketwired - Wed Mar 02, 4:07PM CST
Simavita Limited (ASX: SVA)(TSX VENTURE: SV) ("Simavita" or the "Company"

advises that following the Company's shareholder meeting on February 26, 2016 and approval of Resolution 3, it has allotted a total of 6,666,667 shares (represented by 6,666,667 CHESS Depository Interests ("CDIs"

) and 1,333,333 unlisted options (the "Placement Options"

which are issued on the basis of one attaching Placement Option for every five shares issued pursuant to the placement. Each Placement Option will entitle the holder to acquire one share/CDI in the Company at an exercise price of AUD$0.15 on or before 2 March 2017 to Dussman Pty Ltd. The issue of the CDIs at an issue price of AUD$0.15 per CDI raised $1,000,000.
SV.VN: 0.035 (-0.005), SVA: 5.98 (+0.06)

Simavita Limited: Results of Security Purchase Plan
Marketwired - Fri Feb 19, 11:23AM CST
Simavita Limited (ASX: SVA) (TSX VENTURE: SV) ("Simavita" or the "Company"

refers to the Security Purchase Plan (SPP) announced and opened on January 22, 2016 and closed on February 12, 2016.
SV.VN: 0.035 (-0.005), SVA: 5.98 (+0.06)

Simavita Limited: Release of Restricted Securities
Marketwired - Fri Feb 05, 12:57PM CST
Simavita Limited (ASX: SVA)(TSX VENTURE: SV) ("Simavita" or the "Company"

announces the release of restricted securities from ASX escrow (Restricted Securities).
SV.VN: 0.035 (-0.005), SVA: 5.98 (+0.06)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Postal Connections Expands with New Hillsboro Opening

Expanding Horizons in Hillsboro In the world of postal and office services, Annex Brands, Inc. is making headlines by launching yet another Postal Connections spot, this time planting its flag in the tech-centric town of Hillsboro, Oregon. Spearheaded by Jason Rautenkranz, this expansion is more than just another dot on a map—it's a strategic push into one of the...

Perk's U.S. Expansion: A Bold Move in Spend Control

Perk Aims for U.S. Growth: Will It Pay Off? Amidst the cacophony of market chatter, Perk's announcement to bring its spend platform stateside is echoing louder than usual. This move is not just another step in its expansion but rather a leap considering the competition and market needs. In Europe, where they've already captured a chunk of the market with their Travel and...

Cabot Wilds: Nova Scotia's Next Luxury Golf Haven

Breaking New Ground in Golf and Luxury Cabot and the Bragg family are cooking up something extraordinary in Cumberland County, Nova Scotia. The new luxury lifestyle and golf destination, Cabot Wilds, promises to be more than just a retreat—it's a bold statement on how to marry nature, luxury, and community. Set to open in late 2027, this expansive 2,500-acre resort will...

Feeding Families Foundation Gains $121,500 for NYC Push

Holy smokes, here comes some good news in the nonprofit corners! Feeding Families Foundation just got a hefty $121,500 boost from the Association of Contracting Plumbers of the City of New York Inc. This ain't just some pocket change; it's a full-fledged lifeline that helps them keep on delivering meals to parents who are practically living at their kid’s hospital...

TWP & Commbi Unveil Exclusive Pony Clog Collaboration

A Fusion of Fashion and Functionality Walk down the streets of New York or hustle your way through an airport without worrying about your footwear weighing you down. That's the promise coming from the fresh alliance between TWP and Commbi with their new Pony Clog Collaboration. A blend of high fashion and everyday utility, these clogs aren't just keeping up with the...

Citrine Finalizes Sale of Illinois Senior Living Asset

Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...

Avive Partners with Cambridge Fire for Lifesaving Training

Tapping into the Pulse: Avive & Cambridge Fire in Action No fooling around here—Avive Solutions is linking arms with the Cambridge Fire Department to put the city on a faster track to becoming a lifesaver haven. They're rolling out a free CPR and AED training right in the Smith Campus Center, Harvard Square. It's the kind of thing you love to see—getting the community...

Lumicell Expands LumiSystem in Breast Cancer Surgery

Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...

Orthopedic Expert Highlighting Midwest Pain Access Gaps

Over in the vast sprawl of rolling plains and prairie winds, folks in the Upper Midwest are grappling with an ironic reality. As technological advancements blaze trails, people suffering from vertebrogenic pain are finding themselves up against a wall of limited access to specialized care. We’ve got Dr. James T. Brunz, the man of the hour, one of only about 15 Intracept...

BMAP Expands: Bridging Borders in Legal Advocacy

Breaking Down BMAP's Unique Approach Just when you thought you've seen it all, along comes LMU Loyola Law School swinging the doors wide open with their Binational Migrant Advocacy Project, or as we’re affectionately calling it, BMAP. It's a mouthful, sure, but ain't it something? This project isn't just another feather in academia's cap—it's a relentless counterpunch...